Moreover, in our previous research, we found a dramatic reduction in the percentage of circulating T cell subsets (including CD4+ T cell, CD8+ T cell, and NKT cells) after stroke, which was ameliorated by RIPC after stroke [8]. The gene discussed is CD4; the disease is Stroke.